Amanta Healthcare Ltd
₹
None%
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ 489 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 46.6
- Book Value ₹
- Dividend Yield %
- ROCE 15.7 %
- ROE 15.8 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 20.6% CAGR over last 5 years
- Company's working capital requirements have reduced from 24.7 days to 16.1 days
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 8.30% over past five years.
- Company has a low return on equity of 6.21% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 184 | 171 | 225 | 259 | 280 | 275 | |
| 147 | 133 | 173 | 206 | 223 | 215 | |
| Operating Profit | 37 | 38 | 52 | 53 | 57 | 60 |
| OPM % | 20% | 22% | 23% | 20% | 21% | 22% |
| 2 | 1 | 76 | 4 | 1 | 1 | |
| Interest | 38 | 40 | 49 | 35 | 34 | 28 |
| Depreciation | 16 | 17 | 17 | 18 | 20 | 18 |
| Profit before tax | -15 | -18 | 62 | 3 | 5 | 15 |
| Tax % | 25% | 23% | 11% | 179% | 32% | 29% |
| -19 | -22 | 55 | -2 | 4 | 10 | |
| EPS in Rs | ||||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 7% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 41% |
| TTM: | 189% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | 6% |
| Last Year: | 16% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 27 | 27 | 27 | 27 | 27 | |
| Reserves | 2 | -20 | 36 | 36 | 39 | |
| 231 | 235 | 226 | 216 | 205 | ||
| 127 | 150 | 104 | 96 | 81 | ||
| Total Liabilities | 388 | 392 | 392 | 374 | 352 | |
| 244 | 242 | 240 | 232 | 226 | ||
| CWIP | 0 | 0 | 0 | 9 | 5 | |
| Investments | 0 | 2 | 3 | 0 | 0 | |
| 144 | 149 | 149 | 133 | 120 | ||
| Total Assets | 388 | 392 | 392 | 374 | 352 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 58 | 47 | |||||
| -10 | -24 | |||||
| -46 | -23 | |||||
| Net Cash Flow | 1 | -1 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 104 | 110 | 73 | 75 | 63 | |
| Inventory Days | 225 | 422 | 338 | 247 | 206 | |
| Days Payable | 99 | 186 | 185 | 130 | 86 | |
| Cash Conversion Cycle | 229 | 345 | 226 | 193 | 183 | |
| Working Capital Days | 127 | -5 | 28 | 42 | 16 | |
| ROCE % | 9% | 14% | 13% | 14% |
Documents
Annual reports
No data available.